The study, drawn from data gathered during West African Ebola Virus Disease (EVD) outbreak in 2014–2015, involved 360 patients diagnosed with the virus. The results found that the mortality rate among patients given the antibiotic fell to just more than half—54.7%, compared to a death rate of more than 73% among those who did not …
To ensure quality mental health care is more widely available for those affected by conflict and crises, International Medical Corps launched a toolkit today that will help the humanitarian community better integrate mental health into primary health care programs. The Toolkit for the Integration of Mental Health into General Healthcare in Humanitarian Settings is an …
The global health community is better prepared to face the largest outbreak of Ebola Virus Disease since the 2014-2016 West African epidemic claimed more than 11,000 lives, but funding from major donor countries is needed quickly to contain the current outbreak early. We talk with Dr. Adam Levine, the technical lead of International Medical Corps’ …
Public health specialists who engaged in research while responding to the 2014-2016 Ebola Virus Disease (EVD) outbreak in West Africa have concluded that conducting such work in the midst of a major humanitarian crisis is both possible and can yield valuable guidance when preparing for future infectious disease outbreaks. The three experts, Adam Levine, Primary …
Despite resource and logistical constraints, International Medical Corps cared for thousands at 5 Ebola treatment units in Liberia and Sierra Leone between 2014 and 2015 while collecting hundreds of data points on each patient.
During the West Africa Ebola outbreak, International Medical Corps and Scripps Translational Science Institute (STSI) tested the feasibility of a wireless patient monitoring system in providing real-time, remote monitoring of patient signs inside an Ebola treatment facility. The three-week trial took place in International Medical Corps’ Ebola Treatment Center (ETC) in Makeni, Sierra Leone and …
Ebola invariably caused deaths in the communities where it spread across Guinea, Liberia, Sierra Leone, and elsewhere. It also brought about an unparalleled level of awareness of the disease and, consequently, a number of solutions to combat it effectively. Highlight™ stands out as a noteworthy discovery among the numerous initiatives devised by students and scholars …
The drug ZMapp, viewed as perhaps the most promising potential treatment for Ebola, seemed to prevent death from the disease in its first rigorous clinical trial.
The first controlled trial of an experimental Ebola drug on humans has produced promising results. Initial findings of the trial that ran through the second half of 2015 into January 2016 for the three-component antibody cocktail known as ZMapp showed that patients suffering from the potentially deadly Ebola Virus Disease (EVD) tolerated the drug well …
